As of close of business last night, Precigen Inc’s stock clocked out at $1.36, down -2.86% from its previous closing price of $1.40. On the day, 847870 shares were traded.
Ratios:
To gain a deeper understanding of PGEN’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 2.99 and its Current Ratio is at 2.99. In the meantime, Its Debt-to-Equity ratio is 0.06 whereas as Long-Term Debt/Eq ratio is at 0.05.
On November 18, 2022, Cantor Fitzgerald started tracking the stock assigning a Overweight rating and target price of $7.Cantor Fitzgerald initiated its Overweight rating on November 18, 2022, with a $7 target price.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Dec 28 ’23 when KIRK RANDAL J bought 96,686 shares for $1.41 per share. The transaction valued at 136,327 led to the insider holds 1,096,686 shares of the business.
KINDLER JEFFREY B sold 96,686 shares of PGEN for $136,327 on Dec 28 ’23. The Director now owns 238,275 shares after completing the transaction at $1.41 per share. On Sep 22 ’23, another insider, MITCHELL DEAN J, who serves as the Director of the company, bought 25,000 shares for $1.41 each. As a result, the insider paid 35,250 and bolstered with 356,836 shares of the company.
Valuation Measures:
For the stock, the TTM Price-to-Sale (P/S) ratio is 54.43 while its Price-to-Book (P/B) ratio in mrq is 2.86.
Stock Price History:
Over the past 52 weeks, PGEN has reached a high of $1.88, while it has fallen to a 52-week low of $0.84.
Shares Statistics:
A total of 248.92M shares are outstanding, with a floating share count of 122.70M. Insiders hold about 50.71% of the company’s shares, while institutions hold 30.79% stake in the company.
Earnings Estimates
As of right now, Agenus Inc. analysts gave their recommendation on the stock of the company. The consensus estimate for the next quarter is $2.03, with high estimates of $1.30 and low estimates of $1.36.
Analysts are recommending an EPS of between $Healthcare and $Healthcare for the fiscal current year, implying an average EPS of $Healthcare.
